Malignant neoplasm

No definition available.

Endpoint definition

FinnGen phenotype data
diagram bullet diagram downward connector

Filter registries KELA purch., KELA reimb.

KELA reimbursements: KELA codes 115|116

Check pre-conditions None

Check conditions None

Apply sex-specific rule None

diagram downward connector C3_CANCER

Extra metadata

Level in the ICD hierarchy 1
First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 51262 28084 23178
Unadjusted prevalence (%) 19.71 19.11 20.50
Mean age at first event (years) 60.81 57.53 64.77

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.05 3.49 [3.19, 3.83] <1e-100 9154
15 years 0.03 4.25 [3.93, 4.60] <1e-100 8266
5 years 0.01 9.37 [8.65, 10.15] <1e-100 5281
1 year 0.00 22.96 [20.06, 26.28] <1e-100 2562

Correlations

Index endpoint: C3_CANCER – Malignant neoplasm
GWS hits: 25

Survival analyses between endpoints

Plot

before Malignant neoplasm
after Malignant neoplasm

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Malignant neoplasm